PREVYMIS 120 mg, granules in a sachet 30 sachets
Active ingredients: LÉTERMOVIR
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Granules30 sachetsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- PREVYMIS 120 mg, granulés en sachet
- Pharmaceutical form
- granulés
- Route of administration
- orale
- Presentation description
- 30 sachet(s) polytéréphtalate (PET) aluminium PEBDL : polyéthylène à basse densité linéaire
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Jun 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67216514CIP73031903CIP133400930319031Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉTERMOVIRgranulés | 120 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.